aXichem AB (OSTO:AXIC A) 1-Year Sharpe Ratio: 0.09 (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:AXIC A aXichem AB OSTO:AXIC A
63 GF Score
Price kr1.78
GF Value kr2.52
Valuation Significantly Undervalued
View Full Analysis

What is aXichem AB 1-Year Sharpe Ratio?

aXichem AB OSTO:AXIC A +2.90% 63 1-Year Sharpe Ratio is 0.09 as of Sep. 16, 2026. GuruFocus rates OSTO:AXIC A with a GF Score™ of 63/100 and a GF Value™ of kr2.52 (Significantly Undervalued).

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-09-16), aXichem AB's 1-Year Sharpe Ratio is 0.09.

aXichem AB  (OSTO:AXIC A) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

aXichem AB 1-Year Sharpe Ratio Related Terms

OSTO:AXIC A vs LIN, SHW, ECL: 1-Year Sharpe Ratio Comparison

For the Specialty Chemicals subindustry, aXichem AB's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

aXichem AB 1-Year Sharpe Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, aXichem AB's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where aXichem AB's 1-Year Sharpe Ratio falls into.


OSTO:AXIC A
63GF Score
aXichem AB OSTO:AXIC A
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aXichem AB 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.09 mean?
aXichem AB (OSTO:AXIC A) has a 1-Year Sharpe Ratio of 0.09 as of Sep. 16, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for aXichem AB and its competitors.
Is aXichem AB's 1-Year Sharpe Ratio too high?
aXichem AB's current 1-Year Sharpe Ratio is 0.09. Overall, aXichem AB has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's 1-Year Sharpe Ratio compare to LIN and SHW?
aXichem AB's 1-Year Sharpe Ratio of 0.09 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Chemicals company?
A good 1-Year Sharpe Ratio depends on the Chemicals industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for aXichem AB and its competitors. aXichem AB's current 1-Year Sharpe Ratio is 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
Based on GuruFocus' analysis, aXichem AB (OSTO:AXIC A) is currently considered Significantly Undervalued. The stock's GF Value™ is kr2.52, compared to a current price of kr1.78 — trading 29.6% below its estimated fair value. The current 1-Year Sharpe Ratio is 0.09. aXichem AB's overall GF Score™ is 63/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For aXichem AB (OSTO:AXIC A), the current 1-Year Sharpe Ratio is 0.09 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aXichem AB (OSTO:AXIC A) Overvalued in 2026?

Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued. The current stock price of kr1.78 is trading 29.6% below its estimated GF Value™ of kr2.52. GuruFocus considers aXichem AB to be Significantly Undervalued.

Key valuation signals for OSTO:AXIC A:

  • 1-Year Sharpe Ratio: 0.09
  • GF Value™: kr2.52 vs. price of kr1.78 (29.6% below fair value)
  • GF Score™: 63/100

No single metric tells the full story. See the OSTO:AXIC A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

aXichem AB Business Description

Address Sodergatan 26, Malmo, NOR, 211 34
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
63GF Score

Get the complete analysis for OSTO:AXIC A

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.78
Price
kr2.52
GF Value